Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2C-T-4

From Wikipedia, the free encyclopedia

Pharmaceutical compound
2C-T-4
Clinical data
Other names4-Isopropylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-isopropylthiophenethylamine
Routes of
administration
Oral[1]
Drug classSerotonin;5-HT2 receptoragonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Pharmacokinetic data
Onset of action30 minutes–2 hours[1]
Peak: 3 hours[1]
Duration of action12–18 hours[1]
Identifiers
  • 2-{2,5-Dimethoxy-4-[(propan-2-yl)sulfanyl]phenyl}ethan-1-amine
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC13H21NO2S
Molar mass255.38 g·mol−1
3D model (JSmol)
  • CC(C)Sc1cc(OC)c(cc1OC)CCN
  • InChI=1S/C13H21NO2S/c1-9(2)17-13-8-11(15-3)10(5-6-14)7-12(13)16-4/h7-9H,5-6,14H2,1-4H3 checkY
  • Key:HDYZSVKZKDPLDT-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

2C-T-4, also known as4-isopropylthio-2,5-dimethoxyphenethylamine, is apsychedelic drug of thephenethylamine and2C families.[1][2] It is takenorally.[1]

2C-T-4 was first described in thescientific literature byAlexander Shulgin and colleagues in 1991.[3] Shortly after this, Shulgin described 2C-T-17 in greater detail in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1]

Use and effects

[edit]

In his bookPiHKAL (Phenethylamines I Have Known and Loved),Alexander Shulgin lists 2C-T-4's dose range as 8 to 20 mgorally and itsduration as 12 to 18 hours.[1] Itsonset is 30 minutes to 2 hours and peak effects occur after 3 hours.[1] The effects of 2C-T-4 have been described and includepsychedelic visuals among others.[1] Shulgin devoted a chapter in the first part ofPiHKAL to 2C-T-4, describing an intense "plus-four" experience on theShulgin Rating Scale with a 12 mg dose.[1]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

2C drugs aremetabolized by themonoamine oxidase (MAO)enzymesMAO-A andMAO-B.[4][5]Monoamine oxidase inhibitors (MAOIs) such asphenelzine,tranylcypromine,moclobemide, andselegiline may potentiate the effects of 2C drugs.[4][5][6] This may result inoverdose and serioustoxicity.[6][4]

Pharmacology

[edit]

Pharmacodynamics

[edit]
2C-T-4 activities
TargetAffinity (Ki, nM)
5-HT1A470–916
5-HT1BND
5-HT1DND
5-HT1END
5-HT1FND
5-HT2A27.9–54 (Ki)
5.5–220 (EC50Tooltip half-maximal effective concentration)
56–87% (EmaxTooltip maximal efficacy)
5-HT2BND (Ki)
63–160 (
EC50)
68–75% (
Emax)
5-HT2C180–295 (Ki)
ND (EC50)
ND (Emax)
5-HT3ND
5-HT4ND
5-HT5AND
5-HT6ND
5-HT7ND
α1A11,000
α1B,α1DND
α2A130–217
α2B,α2CND
β1β3ND
D120,000
D216,000
D319,000
D4,D5ND
H1>25,000
H2H4ND
M1M5ND
I1ND
σ1,σ2ND
TAAR1Tooltip Trace amine-associated receptor 12,337–4,500 (Ki) (mouse)
19–53 (Ki) (rat)
3,700 (EC50) (mouse)
83 (
EC50) (rat)
>30,000 (
EC50) (human)
51% (
Emax) (mouse)
67% (
Emax) (rat)
SERTTooltip Serotonin transporter>30,000 (Ki)
113,000 (IC50Tooltip half-maximal inhibitory concentration)
ND (EC50)
NETTooltip Norepinephrine transporter17,000 (Ki)
134,000 (IC50)
ND (EC50)
DATTooltip Dopamine transporter>30,000 (Ki)
294,000 (IC50)
ND (EC50)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified.Refs:[7][8][9][10]

2C-T-4 acts as aserotonin5-HT2 receptoragonist, including of the serotonin5-HT2A receptor.[9][8] The mechanism that produces 2C-T-4's hallucinogenic effects has not been specifically established, however it is most likely to result from 5-HT2A receptor activation in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.

Chemistry

[edit]

2C-T-4 is the2-carbonhomologue ofAleph-4.[1] The full chemical name is 2-[4-(isopropylthio)-2,5-dimethoxyphenyl]-ethanamine.[1] The drug hasstructural andpharmacodynamic properties similar to2C-T-7 and2C-T-19.[1] A notableanalogue of 2C-T-4 is theΨ-PEA compoundΨ-2C-T-4.[1]

Synthesis

[edit]

Thechemical synthesis of 2C-T-4 has been described.[1]

Analogues

[edit]

Analogues of 2C-T-4 include2C-T,2C-T-2,2C-T-7, andAleph-4, among others.[1]

History

[edit]

2C-T-4 was first described in thescientific literature byAlexander Shulgin and colleagues in ajournal article in 1991.[3] Shortly thereafter, it was described in greater detail by Shulgin in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1]

Society and culture

[edit]

Legal status

[edit]

Canada

[edit]

As of October 31, 2016, 2C-T-4 is a controlled substance (Schedule III) in Canada.[11]

China

[edit]

As of October 2015 2C-T-4 is a controlled substance in China.[12]

Denmark

[edit]

2C-T-4 is added to the list of Schedule B controlled substances.[13]

Sweden

[edit]

Sveriges riksdags health ministryStatens folkhälsoinstitut classified 2C-T-4 as "health hazard" under the actLagen om förbud mot vissa hälsofarliga varor (translatedAct on the Prohibition of Certain Goods Dangerous to Health) as of Jul 15, 2007, in their regulation SFS 2007:600 listed as 2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4), making it illegal to sell or possess.[14]

United States

[edit]

As of July 9, 2012, 2C-T-4 is a Schedule I substance in the United States, under the Synthetic Drug Abuse Prevention Act of 2012.[15]

See also

[edit]

References

[edit]
  1. ^abcdefghijklmnopqrShulgin A,Shulgin A (September 1991).PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press.ISBN 0-9630096-0-5.OCLC 25627628.
  2. ^Shulgin A, Manning T, Daley P (2011).The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press.ISBN 978-0-9630096-3-0.
  3. ^abShulgin AT, Shulgin A, Jacob P (January 1991)."Letters to the Editor [Re: Stolaroff (1990) - Central Nervous System (CNS) Activity of Two New Psychoactive Compounds]".Journal of Psychoactive Drugs.23 (1):95–96.doi:10.1080/02791072.1991.10472583.eISSN 2159-9777.ISSN 0279-1072.PMID 1941371. Archived fromthe original on 2025-07-13.
  4. ^abcDean BV, Stellpflug SJ, Burnett AM, Engebretsen KM (June 2013)."2C or not 2C: phenethylamine designer drug review".J Med Toxicol.9 (2):172–178.doi:10.1007/s13181-013-0295-x.PMC 3657019.PMID 23494844.
  5. ^abTheobald DS, Maurer HH (January 2007). "Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series)".Biochem Pharmacol.73 (2):287–297.doi:10.1016/j.bcp.2006.09.022.PMID 17067556.
  6. ^abHalman A, Kong G, Sarris J, Perkins D (January 2024)."Drug-drug interactions involving classic psychedelics: A systematic review".J Psychopharmacol.38 (1):3–18.doi:10.1177/02698811231211219.PMC 10851641.PMID 37982394.
  7. ^"Kᵢ Database".PDSP. 9 May 2025. Retrieved9 May 2025.
  8. ^abRickli A, Luethi D, Reinisch J, Buchy D, Hoener MC, Liechti ME (December 2015)."Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)"(PDF).Neuropharmacology.99:546–553.doi:10.1016/j.neuropharm.2015.08.034.PMID 26318099.
  9. ^abLuethi D, Trachsel D, Hoener MC, Liechti ME (May 2018)."Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)".Neuropharmacology.134 (Pt A):141–148.doi:10.1016/j.neuropharm.2017.07.012.PMID 28720478.
  10. ^Simmler LD, Buchy D, Chaboz S, Hoener MC, Liechti ME (April 2016)."In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1"(PDF).J Pharmacol Exp Ther.357 (1):134–144.doi:10.1124/jpet.115.229765.PMID 26791601. Archived fromthe original(PDF) on 2025-05-09.
  11. ^"Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)".Canada Gazette. 4 May 2016.
  12. ^"关于印发《非药用类麻醉药品和精神药品列管办法》的通知" [Notice on the issuance of the "Regulations on the Listing of Non-Medicinal Narcotic Drugs and Psychotropic Drugs"] (in Chinese). China Food and Drug Administration. 27 September 2015. Archived fromthe original on 1 October 2015. Retrieved1 October 2015.
  13. ^"Bekendtgørelse om euforiserende stoffer" [Executive Order on Euphoriant Drugs].Retsinformation (legal information) (in Danish).
  14. ^Larsson M (14 June 2007)."Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor" [Ordinance amending the Ordinance (1999:58) on the prohibition of certain goods hazardous to health](PDF).Svensk författningssamling (Swedish Constitution) (in Swedish). Archived fromthe original(PDF) on September 29, 2013. RetrievedJanuary 24, 2022.
  15. ^Portman RJ."Synthetic Drug Abuse Prevention Act of 2012". Govtrack. Retrieved22 July 2012.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
TAAR1Tooltip Trace amine-associated receptor 1
Agonists
Endogenous
Exogenous
Antagonists
Inverse agonists
TAAR5Tooltip Trace amine-associated receptor 5
Agonists
Inverse agonists
Notes: (1) TAAR1 activity of ligands varies significantly between species. Some agents that are TAAR1 ligands in some species are not in other species. This navbox includes all TAAR1 ligands regardless of species. (2) See the individual pages for references, as well as theList of trace amines,TAAR, andTAAR1 pages.
See also:Receptor/signaling modulators
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=2C-T-4&oldid=1323881838"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp